
ADC Therapeutics Announces Preclinical Data Highlighted At The American Association For Cancer Research Annual Meeting ...
(MENAFN- PR Newswire) Oral presentation shows ADCT-242 targeting Claudin-6 was well-tolerated and demonstrated potent antitumor activity in ovarian and non-small lung cancer Poster presentations highlight antitumor activity and safety of novel PSMA- …